Characteristics | ||
No. of respondents | 260 | |
Age | ||
Mean (SD) | 68 | (10) |
Range | 40–90 | |
Male | 175 | 67% |
Tumour stage | ||
IA | 56 | (22%) |
IB | 56 | (22%) |
IIA | 10 | (4%) |
IIB | 30 | (12%) |
IIIA | 47 | (18%) |
IIIB | 59 | (23%) |
IV | 2 | (1%) |
Initial treatment | ||
Surgery | 114 | (44%) |
Radiotherapy and chemotherapy | 68 | (26%) |
Surgery and chemotherapy | 27 | (10%) |
Radiotherapy | 22 | (9%) |
Radiotherapy, chemotherapy and surgery | 19 | (7%) |
Radiotherapy and surgery | 7 | (3%) |
Chemotherapy | 3 | (1%) |
Survival time (years) | ||
Mean (SD) | 2.59 | (0.99) |
Range | 0.82–4.76 | |
Recurrence at time of completion | ||
No | 189 | (73%) |
Yes, local and/or regional | 16 | (6%) |
Yes, distant metastases | 20 | (8%) |
Unknown | 35 | (14%) |
Values are numbers (percentages) unless stated otherwise.